Evidence map›Paper›PMID 39125664›Full record

ArticleInternational journal of molecular sciences2024

Association of

Farzana Jasmine, Armando Almazan, Yuliia Khamkevych, Marc Bissonnette, Habibul Ahsan, Muhammad G Kibriya

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. [Relationship betweenZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Article
  3. Article
  4. Review
  5. Differential effects of theWorld journal of gastrointestinal surgery · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Farzana JasmineInstitute for Population and Precision Health, Biological Sciences Division, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-5980-1174
Armando AlmazanInstitute for Population and Precision Health, Biological Sciences Division, The University of Chicago, Chicago, IL 60637, USA.
Yuliia KhamkevychInstitute for Population and Precision Health, Biological Sciences Division, The University of Chicago, Chicago, IL 60637, USA.
Marc BissonnetteDepartment of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Habibul AhsanInstitute for Population and Precision Health, Biological Sciences Division, The University of Chicago, Chicago, IL 60637, USA.
Muhammad G KibriyaInstitute for Population and Precision Health, Biological Sciences Division, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-9784-6958

Funding

Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI RICHARD D MINSHALL · 2017 to 2026
$13.6M
Bangladesh Center of Research Excellence in Non-communicable Disease- Planning UnitP20CA210305 · NCI · UNIVERSITY OF CHICAGO · PI AHSAN, HABIBUL · 2016 to 2017
$524k
NCI NIH HHS P20 CA210305NIEHS NIH HHS P30 ES027792NIH HHS P20CA210305NIH HHS P30ES027792
6 · The paper itself

Abstract

Kirsten Rat Sarcoma (

Indexed as

Colorectal NeoplasmsDNA MethylationGene Expression Regulation, NeoplasticMutationProto-Oncogene Proteins p21(ras)TranscriptomeAgedCyclin-Dependent Kinase Inhibitor p16EpigenomeFemaleGene Expression ProfilingHumansMaleMicrosatellite InstabilityMiddle AgedCyclin-Dependent Kinase Inhibitor p16KRAS protein, humanProto-Oncogene Proteins p21(ras)CDKN2Acolorectal carcinomaEGFRKRAS mutationMSIproteasome inhibitorVEGFVillosol

Identifiers

PMID39125664
PMCPMC11311678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.